PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F0DBD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $42,698
Award facts
- Contract value 100% obligated
- $42,697.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $42,697.86 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), with an ultimate completion date of January 13, 2026. This firm fixed-price contract, which received no set-aside designation, represents a competitive award to the pharmaceutical distributor's corporate office based in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's substantial $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and running through December 2026. This parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (UEI: NWEGNLYTBDW4), which does business as AmerisourceBergen and maintains the overarching parent IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. The parent company's contract portfolio demonstrates extensive capability in fulfilling federal pharmaceutical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order reflects AmerisourceBergen's continued role as a critical vendor supporting military and federal medical supply needs through a flexible and competitively awarded contract structure.
Quick answers
Who was awarded contract SPE2D826F0DBD?
SPE2D826F0DBD was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 12, 2026.
How much is contract SPE2D826F0DBD worth?
The government has obligated $42,698 on SPE2D826F0DBD.
Is contract SPE2D826F0DBD an order under another contract?
Yes. SPE2D826F0DBD is a delivery order under SPE2DX22D0129, an indefinite delivery contract.
Was contract SPE2D826F0DBD competed?
The extent of competition for SPE2D826F0DBD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award